On the web-site of Karolinska Institutet, there is a recent press release regarding a study published in Science Translational Medicine. Read more: Press release in English HIF-1α inhibitor PX-478 preserves pancreatic β cell function in diabetes Ny strategi för att bevara insulinproducerande celler vid diabetes På Karolinska Institutets hemsida finns en nyligen publicerad pressrelease …
Aktieägarna i Biocrine AB kallas härmed till årsstämma tisdagen den 27 juni 2022 kl 15:00 på Mäster Samuelsgatan 42, våning 10 sal Dialog, Stockholm. Avstämningsdag: 2022-06-16 Sista anmälningsdag: 2022-06-22 Mer information angående årsstämman finns HÄR.
As published on the website of Novo Nordisk Foundation, a Phase 1 clinical trial intended to reveal whether islet transplantation to the anterior eye chamber of people with type 1 diabetes could help restore insulin secretion to maintain glucose levels, is led by Professor Per-Olof Berggren at Karolinska Institutet in Sweden. The Novo Nordisk Foundation …
Aktieägarna i Biocrine AB kallas härmed till årsstämma tisdagen den 22 juni 2021 kl 13:00 på Mäster Samuelsgatan 42, våning 10, Stockholm. Avstämningsdag: 2021-06-14 Sista anmälningsdag: 2021-06-18 För att minska risken för smittspridning kommer årsstämman 2021 att hållas kort och formell. Om möjlighet ges kommer aktieägarna att senare inbjudas till ett längre informationsmöte i …
Intake of a high-fat diet leads to an increased risk for obesity, type 2 diabetes, cardiovascular diseases and fatty liver. A study in mice from Karolinska Institutet shows that it is possible to eliminate the deleterious effects of a high-fat diet by lowering the levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism. …
Newly published article in Nano Letters about a novel technique to monitor intraocular pressure. Access to the abstract of this article is found HERE.
Newly published article in Scientific Reports (www.nature.com/scientificreports) about the development of a novel platform for intravital 3D imaging of RT2 tumours to facilitate real-time studies of cancer progression. Full access to article is found HERE.
As has recently been published on the Karolinska Institutet in Sweden’s website, professor Per-Olof Berggren and his colleagues have brought new insight into the role of the delta cells within the islet of Langerhans and how they may affect glucose homeostasis. Read more: Press release in English Nature Communications volume 10, Article number: 3700 (2019) Nya fynd förklarar indirekt …
On the web-site of Karolinska Institutet, there is a recent press release regarding a study published in Diabetologia, the scientific journal of the European Association for the Study of Diabetes (EASD). The leader of the study is professor Per-Olof Berggren. Read more: Press release in English Diabetologia 2019, Online ISSN 1432-0428 Transplanterade celler avslöjar tidiga …
On the web-site of Karolinska Institutet, there is recent press release about professor Per-Olof Berggren being awarded the ERC Advanced Grant, one of the most prestigious funding programmes for research in Europe. Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet, is now awarded this grant for the second time. Read more: Press release in English …